Tylosin Injection is a macrolide antibiotic dedicated to livestock and poultry, with tylosin as the main component. It exerts antibacterial effects by inhibiting bacterial protein synthesis, and has significant inhibitory and killing effects on Gram-positive bacteria (such as streptococci, staphylococci, etc.) and mycoplasma. It is suitable for the treatment of respiratory infections (such as swine mycoplasmal pneumonia, chicken chronic respiratory disease), digestive tract infections and joint infections caused by sensitive bacteria in livestock and poultry (such as pigs, chickens, cattle, sheep, etc.). Administered by intramuscular injection, the drug can be quickly absorbed and distributed to the whole body tissues, rapidly reaching effective blood concentration and timely controlling infections. It is a commonly used drug in farms for preventing and treating bacterial and mycoplasma infections in livestock and poultry, which can effectively reduce the impact of infections on the growth and production performance of livestock and poultry.
